Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
6 studies found for:    "cerebral cavernous malformation" OR "Hemangioma, Cavernous, Central Nervous System" OR "Cavernous Hemangioma" OR "Cavernous Angioma"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins
Conditions: Cavernous Angioma, Familial;   Cerebral Cavernous Malformations;   Cerebral Cavernous Hemangioma
Intervention: Drug: Simvastatin
2 Recruiting Modifiers of Disease Severity in Cerebral Cavernous Malformations
Conditions: Cavernous Angioma, Familial;   Cerebral Cavernous Malformations;   Cerebral Cavernous Hemangioma
Intervention:
3 Not yet recruiting Atorvastatin Therapy in Cerebral Cavernous Malformation: A Proof of Concept Phase I/II Trial
Condition: Cerebral Cavernous Malformation
Interventions: Drug: Atorvastatin;   Other: Placebo
4 Completed A Prospective Controlled Study on Treatment of Giant Cavernous Hemangiomas of the Liver
Conditions: Laparoscopic Hepatectomy;   Radio-frequency Ablation;   Giant Cavernous Hemangiomas;   Liver
Interventions: Procedure: RFA;   Procedure: hepatectomy
5 Completed Influence of MMP on Brain AVM Hemorrhage
Conditions: Arteriovenous Malformations;   Cavernous Angiomas;   Brain Aneurysms
Intervention: Drug: Doxycycline or Placebo
6 Unknown  Topical Timolol Gel for the Treatment of Infantile Hemangiomas
Condition: Hemangioma
Interventions: Drug: timolol maleate 0.5% gel;   Drug: Placebo vehicle/solution

Indicates status has not been verified in more than two years